Skip to main content

Hope, Concern Surround WHO Green Light of First Malaria Vaccine

RTS,S has several flaws but could still save tens of thousands of lives, experts say.

Written byKatarina Zimmer
| 10 min read
close-up of a mosquito on human skin

Register for free to listen to this article
Listen with Speechify
0:00
10:00

ABOVE: © ISTOCK.COM, MRFIZA

Plasmodium parasites are as stealthy as pathogens come. The malaria-causing single-celled organisms have been adapting to the human lineage for longer than our species has existed, giving them millions of years of training in evading our immune systems and—until recently—an unshakable advantage over vaccine developers.

While SARS-CoV-2, the virus that causes COVID-19, only has 29 proteins, Plasmodium species have thousands. SARS-CoV-2’s spike protein, which it uses to invade human cells, is an obvious bullseye for vaccines, but Plasmodium is a moving target. After mosquitoes inject Plasmodium sporozoites into the bloodstream, the parasites hide away and multiply in liver cells, from which they emerge as bloodborne merozoites, which commence fever-inducing invasions of red blood cells. Some of the parasites shapeshift yet again and are picked up through mosquito bites. For each life stage, Plasmodium transforms its cloak of proteins—a challenge to vaccinologists. Many vaccine efforts have failed ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

  • katya katarina zimmer

    After a year teaching an algorithm to differentiate between the echolocation calls of different bat species, Katarina decided she was simply too greedy to focus on one field of science and wanted to write about all of them. Following an internship with The Scientist in 2017, she’s been happily freelancing for a number of publications, covering everything from climate change to oncology. Katarina is a news correspondent for The Scientist and contributes occasional features to the magazine. Find her on Twitter @katarinazimmer and read her work on her website.

    View Full Profile

Related Topics

Related articles background image
The Scientist October Digest cover
October 2026

Antarctica’s Blood Falls Teems With Mysterious Microbial Life

Miles away from the closest ocean, marine microbes thrive in the red ice and mud around Blood Falls, offering clues to microbial adaptation and past climate events.

View this Issue
Find better biologics faster with Stunner and the AI Developability Workcell

Find better biologics faster with Stunner and the AI Developability Workcell

Unchained Labs
An image of microcentrifuge tubes arranged within colorful laboratory racks.

Choose clarity. Choose speed. Choose MyMass™

Refeyn
Characterizing LNP Heterogeneity With Super-Resolution Imaging

Characterizing LNP Heterogeneity With Super-Resolution Imaging

Oni
Conceptual multicolored image of DNA helices.

Exploring the Most Impactful CRISPR Stories

Promega

Products

A monoclonal antibody surrounded by immune cells and red blood cells

CellRaft AIR: Find the Right Antibody-Producing Cells Faster

Cell Microsystems
Maxwell® Rapid ccfDNA Kit

Maxwell® Rapid ccfDNA Kit: Automated Purification of ccfDNA in Under 30 Minutes

Promega
Leica Biosystems, Tempus, and Paige logos side by side, marking the addition of Paige digital pathology AI tools to the Aperio AI Store.

Oncology Researchers Gain AI Cancer Tools in One Platform

Beckman Coulter Life Sciences Logo

Beckman Coulter Life Sciences Launches Vi-CELL BLU 2.0 Software to Advance Data Integrity and GMP Readiness in Cell Analysis